MARAVAI LIFESCIENCES HLDGS-A (MRVI) Stock News

TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology

Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies

Crude Oil Surges 3%; Delta Air Lines Posts Better-Than-Expected Earnings

Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue

Announces Earnings Release Date

Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue

Announces Earnings Release Date...

Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors

Carl Hull to Retire as Executive Chairman

Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors

Carl Hull to Retire as Executive Chairman...

4 Analysts Have This To Say About Maravai LifeSciences

Maravai LifeSciences Announces November 2024 Investor Conference Schedule

Maravai LifeSciences Announces November 2024 Investor Conference Schedule

SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to...

Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript

MRVI earnings call for the period ending September 30, 2024.

Maravai LifeSciences Reports Third Quarter 2024 Financial Results

Maravai LifeSciences Reports Third Quarter 2024 Financial Results

Announces Agreement to Acquire the DNA and RNA business of Officinae Bio, Advancing Support for Innovative Nucleic Acid R&D SAN DIEGO, Calif., Nov. ...

Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024

SAN DIEGO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services...

TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase

Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits

Maravai Lifesciences Shares Soar After Reported Takeover Offer

Maravai Lifesciences Holdings Inc. shares soared after a report that the company received a takeover offer from Repligen Corp.

Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule

Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule

SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to...

Maravai LifeSciences (MRVI) Q2 2024 Earnings Call Transcript

MRVI earnings call for the period ending June 30, 2024.

Maravai LifeSciences Reports Second Quarter 2024 Financial Results

Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation

Maravai LifeSciences Reports Second Quarter 2024 Financial Results

Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation...

Maravai LifeSciences Appoints Trey Martin to Board of Directors

Maravai announces the appointment of CEO Trey Martin to its Board of Directors, highlighting his leadership, commitment to innovation, and industry experience